Home » Stocks » ISCO

International Stem Cell Corporation (ISCO)

Stock Price: $0.5500 USD 0.0000 (0.00%)
Updated May 4, 2021 9:30 AM EDT - Market closed
Market Cap 3.82M
Revenue (ttm) 7.13M
Net Income (ttm) -2.72M
Shares Out 7.64M
EPS (ttm) -0.36
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 4
Last Price $0.5500
Previous Close $0.5500
Change ($) 0.0000
Change (%) 0.00%
Day's Open 0.5000
Day's Range 0.5000 - 0.5500
Day's Volume 353
52-Week Range 0.3000 - 1.0800

News

There are no news available yet.

About ISCO

International Stem Cell Corporation focuses on the development of therapeutic and biomedical products worldwide. The company's products are based on human parthenogenetic stem cells, a proprietary type of pluripotent stem cell. It develops various cell types, including neural stem cells for the treatment of Parkinson's disease and other central nervous system disorders; liver cells to treat various congenital and acquired liver diseases; and islet cells for the treatment of diabetes. The company also develops, manufactures, and markets skincare... [Read more...]

Industry
Biotechnology
Founded
2001
Stock Exchange
OTCMKTS
Ticker Symbol
ISCO
Full Company Profile

Financial Performance

In 2020, ISCO's revenue was $7.13 million, a decrease of -24.75% compared to the previous year's $9.47 million. Losses were -$2.72 million, -36.13% less than in 2019.

Financial Statements

Analyst Forecasts

The average 12-month stock price forecast for ISCO is 0.54, which is a decrease of -1.82% from the latest price.

Price Target
$0.54
(-1.82% downside)